- Report
- March 2025
- 193 Pages
Global
From €3226EUR$3,545USD£2,766GBP
€3585EUR$3,939USD£3,073GBP
- Report
- March 2025
- 191 Pages
Global
From €3226EUR$3,545USD£2,766GBP
€3585EUR$3,939USD£3,073GBP
- Report
- May 2024
- 186 Pages
Global
From €4095EUR$4,500USD£3,511GBP
- Report
- August 2024
- 150 Pages
Global
From €3413EUR$3,750USD£2,926GBP
- Report
- September 2024
- 117 Pages
Global
From €4095EUR$4,500USD£3,511GBP
- Report
- May 2024
- 250 Pages
Global
From €4546EUR$4,995USD£3,897GBP
- Book
- February 2023
- 208 Pages
The Synthetic Biomaterial market is a subset of the larger Biomaterials market, which encompasses materials used in medical and healthcare applications. Synthetic Biomaterials are man-made materials that are designed to interact with biological systems, such as the human body. These materials are used in a variety of medical applications, including implants, prosthetics, and drug delivery systems. Synthetic Biomaterials are designed to be biocompatible, meaning they are non-toxic and do not cause an immune response. They are also designed to be durable and long-lasting, allowing them to be used in a variety of medical applications.
Some companies in the Synthetic Biomaterial market include Corbion, PolyOne Corporation, Evonik Industries, Solvay, and BASF. Show Less Read more